Büyükkaya, RamazanBeşir, Fahri HalitYazgan, SibelKarataş, AhmetKöse, S.A.Aydın, Y.Erdoğmuş, B.2020-04-302020-04-3020140009-9074https://dx.doi.org/10.7417/CT.2014.1664https://hdl.handle.net/20.500.12684/696PubMed ID: 24589963Purpose. Polycystic ovary syndrome (PCOS) is a common endocrine disorder which is associated with multiple risk factors for atherosclerosis. The aim of this study was to investigate the CIMT which is used in the early diagnosis of atherosclerosis and visceral obesity by ultrasound in newly diagnosed polycystic ovary syndrome with normal body mass index. Materials and Methods. A case-control study was conducted on 25 PCOS women (18-30 years of age) and 25 controls. BMI was matched volunteer controls. Carotid intima media thickness (CIMT) and fat distribution as visceral fat thickness (VFT) with subcutaneous fat thickness (SFT) were measured by ultrasound. After, visceral fat ratio (VFR) fat ratio (VFR) was calculated using VFT divided by SFT. The variables were compared using the ?2-test and Student's t test. Results. Comparing women with PCOS to the control group showed that CIMT was similar in both groups (p=0.84). The VFT in the PCOS group was higher than the control group (p=0.048). Whereas, the SFT was higher in the control group when compared to women with PCOS (p=0.007). The VFR was significantly higher in women with PCOS when compared to the control group (1.12 ± 0.38 vs. 0.81 ± 0.34; p=0.005). Conclusions. CIMT which used as early atherosclerosis predictors have not increased in newly diagnosed PCOS women. Body fat distribution was observed in visceral area in the newly diagnosed PCOS women. VFR follow up may provide benefit as a quantitative method for the assessment and follow up of visceral obesity in women with PCOS. © Società Editrice Universo (SEU).en10.7417/CT.2014.1664info:eu-repo/semantics/closedAccessAtherosclerosis; Ultrasound; Visceral fatThe evaluation of carotid intima-media thickness and visceral obesity as an atherosclerosis predictor in newly-diagnosed polycystic ovary syndromeArticle1651 SUPPLe6e11N/A